Skip to main content
Fig. 6 | Stem Cell Research & Therapy

Fig. 6

From: Allogeneic transplantation of programmable cells of monocytic origin (PCMO) improves angiogenesis and tissue recovery in critical limb ischemia (CLI): a translational approach

Fig. 6

Representative staining of (a) arterioles with endothelial antibodies against CD34 and staining of (b) capillaries with endothelial antibodies against CD105 (red arrows). c Quantification of CD34+ arterioles and CD105+ capillaries demonstrated significantly increased vascular density in the PCMO group at 91 days compared to the native monocytes and placebo group, indicating PCMO have some pro-angiogenic properties (average score value ± standard deviation; *p ≤ 0.038; ***p < 0.0001). Scale bar 200 and 500 μm. PCMO programmable cells of monocytic origin

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512